In this podcast we feature an article about what and who is behind Viatris, the new company formed from the combination of Upjohn, Pfizer’s off-patent branded and generic established medicines business, and Mylan. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Rationale for the new company
- Inside the new Viatris: products
- Inside the new Viatris: manufacturing
- Inside Viatris: leadership, company structure, and cost-savings plan
Sponsor: LabVantage Solutions